Vivid Seats Inc.
Vivid Seats Inc. (SEATW) Financial Performance & Income Statement Overview
Review Vivid Seats Inc. (SEATW) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Vivid Seats Inc. (SEATW) Income Statement & Financial Overview
View the income breakdown for Vivid Seats Inc. SEATW across both annual and quarterly reports.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $143.57M | $164.02M | $199.81M | $186.60M |
| Cost of Revenue | $42.43M | $44.52M | $52.48M | $51.03M |
| Gross Profit | $101.14M | $119.50M | $147.34M | $135.58M |
| Gross Profit Ratio | $0.70 | $0.73 | $0.74 | $0.73 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $100.07M | $113.63M | $128.30M | $113.39M |
| Operating Expenses | $432.86M | $123.82M | $144.43M | $124.81M |
| Total Costs & Expenses | $475.29M | $168.34M | $196.91M | $175.84M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $5.63M | $5.67M | $6.47M | $6.30M |
| Depreciation & Amortization | $12.34M | $11.63M | $14.28M | $10.67M |
| EBITDA | -$45.53M | $10.66M | $17.61M | $30.45M |
| EBITDA Ratio | -$0.32 | $0.06 | $0.09 | $0.16 |
| Operating Income | -$331.73M | -$4.32M | $2.90M | $10.77M |
| Operating Income Ratio | -$2.31 | -$0.03 | $0.01 | $0.06 |
| Other Income/Expenses (Net) | $144.56M | -$2.31M | -$6.04M | $2.72M |
| Income Before Tax | -$187.16M | -$6.63M | -$3.13M | $13.49M |
| Income Before Tax Ratio | -$1.30 | -$0.04 | -$0.02 | $0.07 |
| Income Tax Expense | $76.17M | $3.15M | $1.28M | $4.29M |
| Net Income | -$139.68M | -$5.94M | -$886000.00 | $5.30M |
| Net Income Ratio | -$0.97 | -$0.04 | -$0.004 | $0.03 |
| EPS | -$1.07 | -$0.04 | -$0.007 | $0.04 |
| Diluted EPS | -$0.67 | -$0.05 | -$0.004 | $0.03 |
| Weighted Avg Shares Outstanding | $130.54M | $132.90M | $132.39M | $131.52M |
| Weighted Avg Shares Outstanding (Diluted) | $206.96M | $209.13M | $209.13M | $208.59M |
Over the past four quarters, Vivid Seats Inc. demonstrated steady revenue growth, increasing from $186.60M in Q3 2024 to $143.57M in Q2 2025. Operating income reached -$331.73M in Q2 2025, maintaining a consistent -231% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at -$45.53M, reflecting operational efficiency. Net income dropped to -$139.68M, with EPS at -$1.07. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan